Thomas F. DeLaney, M.D. is a graduate of Harvard College and Harvard Medical School. Following an internship in General Surgery at Yale-New Haven Hospital, he trained in Radiation Oncology at the Massachusetts General Hospital. He then spent 6 years as a Senior Investigator at the National Cancer Institute in Bethesda MD. Since 1992, he has been on the staff of the Massachusetts General Hospital and on the faculty of Harvard Medical School. Currently, he is the Medical Director of the Francis H. Burr Proton Therapy Center at Massachusetts General Hospital, Co-Director of the Center for Sarcoma and Connective Tissue Oncology at Massachusetts General Hospital, and Andres Soriano Professor of Radiation Oncology, Harvard Medical Schoo.

He has served on the Executive Board of the Connective Tissue Oncology Society and the National Comprehensive Cancer Network Soft Tissue Sarcoma Guidelines Panel, and currently serves as a member of the Medical Advisory Board of the Chordoma Foundation. He is active in the Radiation Therapy Oncology Group (now NRG Oncology) Sarcoma and Proton Clinical Trials Working Groups.

Dr. DeLaney is actively involved in clinical research on the treatment of soft tissue and bone sarcomas and as well as the use of charged particle (proton) radiation therapy.  He was the principal investigator of NCI-funded P01 and U19 proton therapy grants from 2005-2016.  His bibliography lists 145 original reports as well as over 100 reviews, book chapters, editorials, and clinical guidelines. He, along with Hanne Kooy, Ph.D. edited the book, Proton and Charged Particle Radiotherapy( Lippincott Williams and Wilkins, Philadelphia, 2007). He has served on the editorial boards of the Journal of Surgical Oncology, Annals of Surgical Oncology, Journal of Clinical Oncology, and UpToDate in Oncology.

For more information about the CARO Lecture, click here.